Particle.news
Download on the App Store

Analysts Reaffirm Bullish Case for Intuitive Surgical as Da Vinci 5 Rollout Accelerates Growth

Recent ratings highlight catalysts from new surgical systems following a pullback from the January high.

Overview

  • Bernstein SocGen reiterated an Outperform rating with a $685 price target on September 4, calling the current range a buy opportunity and pointing to upcoming launches to lift sentiment.
  • Bank of America Securities reaffirmed a Buy on September 10 with a $650 target despite recent share weakness, reinforcing positive near-term expectations.
  • Intuitive reported second‑quarter revenue up 21% year over year to $2.44 billion as the next‑generation da Vinci 5 entered a broad commercial launch phase.
  • A Seeking Alpha author initiated coverage with a Buy and disclosed a long position, citing a dominant installed base, high surgeon adoption, and a razor‑and‑blades model that drives recurring revenue.
  • Bernstein referenced five transformational product launches and said the company has more upside to near‑term EPS estimates than any other stock it covers, while Insider Monkey cited a $597 median 12‑month target implying sizable upside from September 16 levels.